Patenting Life: No

Land, Richard D.; Mitchell, C. Ben
May 1996
First Things: A Monthly Journal of Religion & Public Life;May1996, Issue 63, p20
Focuses on the ethical implications of patenting human genes and genetically engineered animals. Moral and theological concerns raised against the issue; Need for the implementation of policies that reflect a careful and mature moral examination in technological advancements; Capability of the U.S. patent law to deal with the potential abuse of human genetic materials.


Related Articles

  • No room for experiment: the Federal Circuit's narrow construction of the experimental use defense. Ludwig, S. Peter; Chumney, Jason C. // Nature Biotechnology;Apr2003, Vol. 21 Issue 4, p453 

    Reports on the decision of the U.S. Court of Appeals for the Federal Circuit (CAFC) and the premier adjudicator of U.S. patent law, in the case of `Madey v. Duke University,' that makes clear that nonprofit research institutions will now be afforded little, if any, protection under the...

  • Protecting Nanotechnology Inventions: Prosecuting in an Unpredictable World. Mills, Jeffrey K.; Fitzsimmons, Jason A.; Rodkey, Kevin // Nanotechnology Law & Business;2010, Vol. 7 Issue 3, p223 

    Nanotechnology is often considered an unpredictable field. Products and applications are frequently based on the discovery that what may have been true at the macroscale is often much different at the nanoscale. Protecting inventions in such a rapidly developing field can be challenging for...

  • EPA Okays Trials for Arkema Methyl Bromide Alternative. Sissel, Kara // Chemical Week;5/23/2007, Vol. 169 Issue 18, p33 

    The article reports that the U.S. Environmental Protection Agency has granted Arkema an experimental use permit for a new soil fumigant, called Paladin, which the company says is an attractive substitute for methyl bromide. The experimental use permit allows for the product to be applied to a...

  • New rules for gene patents. Grisham, Julie // Nature Biotechnology;Sep2000, Vol. 18 Issue 9, p921 

    Reports on possible release of guidelines by the U.S. Patent and Trademark Office for determining whether a gene-related patent will be granted by the office or not. Need for gene-related patents in research work.

  • MADEY V. DUKE UNIVERSITY: SHATTERING THE MYTH OF UNIVERSITIES' EXPERIMENTAL USE DEFENSE. Cai, Michelle // Berkeley Technology Law Journal;Annual Review 2004, Vol. 19 Issue 1, p175 

    Reports the the Federal Circuit has rejected an experimental use defense to a patent infringement lawsuit against a university in the "Madey v. Duke University" case in Durham, North Carolina. Elimination of the experimental use defense in academic research; Examination of the impact of the...

  • Notices: ENVIRONMENTAL PROTECTION AGENCY.  // Federal Register;3/15/2013, Vol. 78 Issue 51, p16498 

    The article highlights documents other than rules or proposed rules on pesticide experiment use permits, environmental impacts statements and transfer of data by the Environmental Protection Agency (EPA) in the U.S. It announces EPA's receipt for applications that requests for experimental use...

  • TRIALS IN 16 STATES: EUPs for DuPont Insecticides.  // Chem.info;Jun2007, Vol. 45 Issue 5, p51 

    The article reports on the approval of experimental use permits (EUP) for DuPont Altacor and Coragen insecticides for use on 10 fruit and vegetable crops by Environmental Protection Agency (EPA) in 16 states including California, Florida and Texas. Growers will be able to harvest crops treated...

  • Drug patent ruling supports big pharma.  // R&D Magazine;Jul2005, Vol. 47 Issue 7, p10 

    Reports that the U.S. Supreme Court gave drug companies increased latitude to use or experiment with already patented drugs or compounds in the testing phase of new medicines. Statement issued by Justice Antonin Scalia on the protection of pharmaceutical firms from utilizing patented compounds...

  • RESTRICTING EXPERIMENTAL USE. Devlin, Alan // Harvard Journal of Law & Public Policy;Spring2009, Vol. 32 Issue 2, p599 

    The article looks at the normative foundation of the decision of the U.S. Federal Circuit to restrict experimental use of technologies by patent holders. The issue of whether the right of a patentee to prevent others from experimenting on his or her invention is included in his or her power to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics